Keyword Connections

alpha-synuclein

Journals

2

1 advances in experimental medicine and biology

2 journal of parkinson's disease

Research Groups

0

No Research Group Connected

Bibliographies

20

1 Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model.

2 protein phosphorylation in neurodegeneration: friend or foe?

3 Αlpha-synuclein as a mediator in the interplay between aging and parkinson’s disease

4 a novel microfluidic cell co-culture platform for the study of the molecular mechanisms of parkinson’s disease and other synucleinopathies

5 glucocerebrosidase mutations and synucleinopathies. potential role of sterylglucosides and relevance of studying both gba1 and gba2 genes

6 editorial note. golgi pathology in neurodegenerative diseases.

7 a rapid, semi-quantitative assay to screen for modulators of alpha-synuclein oligomerization ex vivo

8 advancing stem cell models of alpha-synuclein gene regulation in neurodegenerative disease

9 Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein.

10 Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology.

11 Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.

12 Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.

13 Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD

14 5-ht2a receptor binding in the frontal cortex of parkinson’s disease patients and alpha-synuclein overexpressing mice: a postmortem study

15 rotenone upregulates alpha-synuclein and myocyte enhancer factor 2d independently from lysosomal degradation inhibition

16 alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection

17 modulation of alpha-synuclein expression and associated effects by microrna let-7 in transgenic c. elegans

18 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model

19 Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies

20 Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease